Top

Cancer Causes & Control

Published in:

01-06-2004

Prevalence of Whole-Body Skin Self-Examination in a Population at High Risk for Skin Cancer (Australia)

Authors: Joanne F. Aitken, Monika Janda, John B. Lowe, Mark Elwood, Ian T. Ring, Philippa H. Youl, David W. Firman

Published in: Cancer Causes & Control | Issue 5/2004

Title: Prevalence of Whole-Body Skin Self-Examination in a Population at High Risk for Skin Cancer (Australia)
Authors: Joanne F. Aitken
Monika Janda
John B. Lowe
Mark Elwood
Ian T. Ring
Philippa H. Youl
David W. Firman
Publication date: 01-06-2004
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 5/2004
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1023/B:CACO.0000036451.39128.f6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2004

Occupational Exposure to Vinyl Chloride, Acrylonitrile and Styrene and Lung Cancer Risk (Europe)

Folate Intake, MTHFR C677T Polymorphism, Alcohol Consumption, and Risk for Sporadic Colorectal Adenoma (United States)

Differences in Testis Cancer Survival by Race and Ethnicity: A Population-Based Study, 1973–1999 (United States)

Better Knowledge Translation for Effective Cancer Control: A Priority for Action

Stem Cells and Prenatal Origin of Breast Cancer

Physical Activity, Body Size, and Estrogen Metabolism in Women

Keynote webinar | Spotlight on antibody–drug conjugates in cancer